Cisplatin and Oral S-1 Show Feasibility in Cancer Patients with Severe Liver Dysfunction
A seven-year prospective trial shows that oral S-1 plus cisplatin preserves overall 5-FU exposure and manageable toxicity in cancer patients ...
A seven-year prospective trial shows that oral S-1 plus cisplatin preserves overall 5-FU exposure and manageable toxicity in cancer patients ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine